newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth

  • INVO Fertility, Inc. (NASDAQ: IVF) issued a shareholder letter from CEO Steve Shum outlining a strengthened fundamental position & strategic outlook for growth.
  • The company has transitioned from recovery & restructuring to expansion, achieving profitability at its three existing operational clinics.
  • INVO is nearing the closing of an acquisition for a fourth clinic in Indianapolis, which will diversify revenue & enhance earnings power.
  • The combined pro forma annualized revenue run rate from all clinics, including the Indianapolis acquisition, is approximately $9 million.
  • Organic growth remains a key value driver focused on increasing patient volumes, optimizing treatment pathways, & enhancing the patient experience.
  • The company maintains a robust & active acquisition pipeline with multiple targets under evaluation & a disciplined selection approach.
  • Recent federal executive actions supporting IVF access & affordability are expected to positively influence patient demand & market certainty.
  • INVO anticipates strong growth in 2026 driven by acquisitions, organic expansion, & rising global infertility rates.
  • A January 2026 warrant inducement issued new financing at a fixed price of $1.59 to simplify & strengthen the capital structure.
  • The company's balance sheet is now the strongest it has been in over three years, providing optionality for acquisitions & growth investments.
  • INVO operates two INVO Centers utilizing its proprietary INVOcell device & one IVF clinic, while also distributing INVOcell to third parties.